ENST00000373827.6:c.96+52910A>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000373827.6(ANK3):​c.96+52910A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0925 in 152,284 control chromosomes in the GnomAD database, including 1,185 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.092 ( 1185 hom., cov: 32)

Consequence

ANK3
ENST00000373827.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.175

Publications

20 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.311 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANK3NM_001204404.2 linkc.63+10189A>G intron_variant Intron 1 of 43 NP_001191333.1
ANK3NM_001204403.2 linkc.96+52910A>G intron_variant Intron 2 of 43 NP_001191332.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANK3ENST00000373827.6 linkc.96+52910A>G intron_variant Intron 2 of 43 1 ENSP00000362933.2
ANK3ENST00000503366.6 linkc.63+10189A>G intron_variant Intron 1 of 43 2 ENSP00000425236.1
ANK3ENST00000510382.1 linkn.101+52910A>G intron_variant Intron 2 of 2 2
ANK3ENST00000622427.4 linkn.63+10189A>G intron_variant Intron 1 of 32 2 ENSP00000483244.1

Frequencies

GnomAD3 genomes
AF:
0.0925
AC:
14076
AN:
152166
Hom.:
1182
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0185
Gnomad AMI
AF:
0.0274
Gnomad AMR
AF:
0.209
Gnomad ASJ
AF:
0.0798
Gnomad EAS
AF:
0.324
Gnomad SAS
AF:
0.176
Gnomad FIN
AF:
0.157
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0797
Gnomad OTH
AF:
0.0865
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0925
AC:
14080
AN:
152284
Hom.:
1185
Cov.:
32
AF XY:
0.100
AC XY:
7476
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.0185
AC:
769
AN:
41574
American (AMR)
AF:
0.210
AC:
3206
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0798
AC:
277
AN:
3470
East Asian (EAS)
AF:
0.324
AC:
1677
AN:
5178
South Asian (SAS)
AF:
0.174
AC:
840
AN:
4828
European-Finnish (FIN)
AF:
0.157
AC:
1663
AN:
10598
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0798
AC:
5425
AN:
68020
Other (OTH)
AF:
0.0880
AC:
186
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
595
1190
1784
2379
2974
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
162
324
486
648
810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.101
Hom.:
2159
Bravo
AF:
0.0960
Asia WGS
AF:
0.251
AC:
869
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
7.4
DANN
Benign
0.87
PhyloP100
0.17
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10994415; hg19: chr10-62322034; API